Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3108142rdf:typepubmed:Citationlld:pubmed
pubmed-article:3108142lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:3108142lifeskim:mentionsumls-concept:C0039195lld:lifeskim
pubmed-article:3108142lifeskim:mentionsumls-concept:C0010592lld:lifeskim
pubmed-article:3108142lifeskim:mentionsumls-concept:C0376249lld:lifeskim
pubmed-article:3108142lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:3108142lifeskim:mentionsumls-concept:C1709634lld:lifeskim
pubmed-article:3108142pubmed:issue1lld:pubmed
pubmed-article:3108142pubmed:dateCreated1987-7-17lld:pubmed
pubmed-article:3108142pubmed:abstractTextA limiting dilution (LD) culture system was used to investigate the effect of cyclosporin A (CsA) on the activation and differentiation of human alloreactive cytotoxic T-lymphocyte precursors (CTL-p). CsA reduced in a dose-dependent fashion the frequency of alloantigen-inducible CTL-p. With most normal individuals tested there was a 20- to 50-fold reduction of alloreactive CTL-p frequencies in the presence of 500-1000 ng/ml CsA. Both unseparated T cells and CD8+ T cells were CsA-sensitive under LD culture conditions. Importantly, however, alloreactive CTL-p from two out of 21 normal individuals were found to be largely CsA-resistant. CsA did not affect the growth of MLR-primed CTL in secondary LD culture. Furthermore, CsA slightly inhibited the cytolytic activity of some alloantigen-specific CTL clones. These results are discussed with respect to the clinical use of CsA in transplantation medicine.lld:pubmed
pubmed-article:3108142pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3108142pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3108142pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3108142pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3108142pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3108142pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3108142pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3108142pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3108142pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3108142pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3108142pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3108142pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3108142pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3108142pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3108142pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3108142pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3108142pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3108142pubmed:languageenglld:pubmed
pubmed-article:3108142pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3108142pubmed:citationSubsetIMlld:pubmed
pubmed-article:3108142pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3108142pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3108142pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3108142pubmed:statusMEDLINElld:pubmed
pubmed-article:3108142pubmed:monthMaylld:pubmed
pubmed-article:3108142pubmed:issn0019-2805lld:pubmed
pubmed-article:3108142pubmed:authorpubmed-author:WagnerHHlld:pubmed
pubmed-article:3108142pubmed:authorpubmed-author:KabelitzDDlld:pubmed
pubmed-article:3108142pubmed:authorpubmed-author:KOCHF WFWlld:pubmed
pubmed-article:3108142pubmed:authorpubmed-author:ZankerBBlld:pubmed
pubmed-article:3108142pubmed:authorpubmed-author:ZankerCClld:pubmed
pubmed-article:3108142pubmed:issnTypePrintlld:pubmed
pubmed-article:3108142pubmed:volume61lld:pubmed
pubmed-article:3108142pubmed:ownerNLMlld:pubmed
pubmed-article:3108142pubmed:authorsCompleteYlld:pubmed
pubmed-article:3108142pubmed:pagination57-62lld:pubmed
pubmed-article:3108142pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:3108142pubmed:meshHeadingpubmed-meshheading:3108142-...lld:pubmed
pubmed-article:3108142pubmed:meshHeadingpubmed-meshheading:3108142-...lld:pubmed
pubmed-article:3108142pubmed:meshHeadingpubmed-meshheading:3108142-...lld:pubmed
pubmed-article:3108142pubmed:meshHeadingpubmed-meshheading:3108142-...lld:pubmed
pubmed-article:3108142pubmed:meshHeadingpubmed-meshheading:3108142-...lld:pubmed
pubmed-article:3108142pubmed:meshHeadingpubmed-meshheading:3108142-...lld:pubmed
pubmed-article:3108142pubmed:meshHeadingpubmed-meshheading:3108142-...lld:pubmed
pubmed-article:3108142pubmed:meshHeadingpubmed-meshheading:3108142-...lld:pubmed
pubmed-article:3108142pubmed:meshHeadingpubmed-meshheading:3108142-...lld:pubmed
pubmed-article:3108142pubmed:year1987lld:pubmed
pubmed-article:3108142pubmed:articleTitleHuman cytotoxic T lymphocytes. II. Frequency analysis of cyclosporin A-sensitive alloreactive cytotoxic T-lymphocyte precursors.lld:pubmed
pubmed-article:3108142pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3108142pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3108142lld:pubmed